By: Andrew A Radin, CEO & Co-founder, Aria Pharmaceuticals There has never been more discussion about the usefulness, and proper use of, artificial intelligence (AI) in drug discovery. When Aria first started utilizing AI as a tool in the early drug discovery process, much of that conversation centered on AI…